Analysts Set Bausch Health Companies Inc (NYSE:BHC) PT at $31.05

Share on StockTwits

Shares of Bausch Health Companies Inc (NYSE:BHC) have been assigned an average rating of “Buy” from the eighteen brokerages that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and twelve have given a buy rating to the company. The average 1-year target price among analysts that have covered the stock in the last year is $31.05.

A number of research analysts recently commented on BHC shares. Cantor Fitzgerald set a $32.00 price objective on Bausch Health Companies and gave the stock a “buy” rating in a research note on Friday, May 31st. Mizuho set a $45.00 price objective on Bausch Health Companies and gave the stock a “buy” rating in a research note on Thursday, June 20th. Piper Jaffray Companies set a $29.00 price objective on Bausch Health Companies and gave the stock a “buy” rating in a research note on Tuesday, June 11th. TD Securities upgraded Bausch Health Companies from a “hold” rating to a “buy” rating and set a $28.00 price target for the company in a research report on Thursday, August 15th. Finally, Wolfe Research assumed coverage on Bausch Health Companies in a research report on Friday, July 19th. They set an “outperform” rating and a $31.00 price target for the company.

Shares of NYSE BHC opened at $22.42 on Friday. Bausch Health Companies has a twelve month low of $17.20 and a twelve month high of $28.45. The company has a current ratio of 1.21, a quick ratio of 0.92 and a debt-to-equity ratio of 8.94. The company has a market capitalization of $7.50 billion, a price-to-earnings ratio of 5.58, a price-to-earnings-growth ratio of 0.25 and a beta of 0.76. The business has a 50 day simple moving average of $23.41 and a 200-day simple moving average of $23.85.

Bausch Health Companies (NYSE:BHC) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $1.03 EPS for the quarter, missing the Zacks’ consensus estimate of $1.06 by ($0.03). The company had revenue of $2.15 billion for the quarter, compared to the consensus estimate of $2.15 billion. Bausch Health Companies had a positive return on equity of 52.12% and a negative net margin of 10.88%. Bausch Health Companies’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.93 earnings per share. As a group, equities analysts predict that Bausch Health Companies will post 4.24 earnings per share for the current year.

In other news, EVP Christina Ackermann sold 3,968 shares of the company’s stock in a transaction on Thursday, July 11th. The stock was sold at an average price of $24.81, for a total value of $98,446.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider William D. Humphries acquired 30,703 shares of the business’s stock in a transaction dated Friday, August 16th. The stock was purchased at an average price of $21.18 per share, with a total value of $650,289.54. The disclosure for this purchase can be found here. Insiders own 11.87% of the company’s stock.

Several institutional investors have recently made changes to their positions in BHC. Highstreet Asset Management Inc. acquired a new stake in shares of Bausch Health Companies during the first quarter worth $354,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Bausch Health Companies by 1.2% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 193,792 shares of the company’s stock worth $4,783,000 after purchasing an additional 2,223 shares during the period. CLARET ASSET MANAGEMENT Corp raised its position in shares of Bausch Health Companies by 9.2% during the first quarter. CLARET ASSET MANAGEMENT Corp now owns 14,751 shares of the company’s stock worth $364,000 after purchasing an additional 1,245 shares during the period. Bank of Montreal Can raised its position in shares of Bausch Health Companies by 28.2% during the first quarter. Bank of Montreal Can now owns 3,702,077 shares of the company’s stock worth $91,441,000 after purchasing an additional 815,311 shares during the period. Finally, Academy Capital Management Inc. TX raised its position in shares of Bausch Health Companies by 3.9% during the first quarter. Academy Capital Management Inc. TX now owns 580,218 shares of the company’s stock worth $14,331,000 after purchasing an additional 21,641 shares during the period. Institutional investors and hedge funds own 57.35% of the company’s stock.

Bausch Health Companies Company Profile

Bausch Health Companies Inc develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products.

Further Reading: Gap Down Stocks

Analyst Recommendations for Bausch Health Companies (NYSE:BHC)

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

CSat Investment Advisory L.P. Increases Stake in Humana Inc
CSat Investment Advisory L.P. Increases Stake in Humana Inc
CSat Investment Advisory L.P. Boosts Stake in PepsiCo, Inc.
CSat Investment Advisory L.P. Boosts Stake in PepsiCo, Inc.
CSat Investment Advisory L.P. Boosts Stake in Alibaba Group Holding Ltd
CSat Investment Advisory L.P. Boosts Stake in Alibaba Group Holding Ltd
CSat Investment Advisory L.P. Cuts Position in Nasdaq Inc
CSat Investment Advisory L.P. Cuts Position in Nasdaq Inc
CSat Investment Advisory L.P. Sells 621 Shares of General Mills, Inc.
CSat Investment Advisory L.P. Sells 621 Shares of General Mills, Inc.
Line Corp  Shares Sold by CSat Investment Advisory L.P.
Line Corp Shares Sold by CSat Investment Advisory L.P.


© 2006-2019 Ticker Report